All Stories

  1. The Contribution of Genetic Sequencing Information to the Identification and Functional Characterization of Two-Pore Domain Potassium (K2P) Channels as Viable Therapeutic Targets

    Article • January 2024, Springer Science + Business Media

    Professor Alistair Mathie

  2. Screening for atrial fibrillation in care homes using pulse palpation and the AliveCor Kardia Mobile® device: a comparative cross-sectional pilot study

    Article • International Journal of Clinical Pharmacy, December 2023, Springer Science + Business Media

    Professor Alistair Mathie

  3. The Concise Guide to PHARMACOLOGY 2023/24: Catalytic receptors

    Article • British Journal of Pharmacology, October 2023, Wiley

    Professor Alistair Mathie, Professor Jamie A Davies

  4. The Concise Guide to PHARMACOLOGY 2023/24: Enzymes

    Article • British Journal of Pharmacology, October 2023, Wiley

    Professor Alistair Mathie, Professor Jamie A Davies

  5. The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors

    Article • British Journal of Pharmacology, October 2023, Wiley

    Professor Alistair Mathie, Professor of Vascular Physiology Lucie Clapp

  6. The Concise Guide to PHARMACOLOGY 2023/24: Introduction and Other Protein Targets

    Article • British Journal of Pharmacology, October 2023, Wiley

    Professor Alistair Mathie

  7. The Concise Guide to PHARMACOLOGY 2023/24: Ion channels

    Article • British Journal of Pharmacology, October 2023, Wiley

    Professor Alistair Mathie, Professor Jamie A Davies

  8. The Concise Guide to PHARMACOLOGY 2023/24: Nuclear hormone receptors

    Article • British Journal of Pharmacology, October 2023, Wiley

    Professor Alistair Mathie, Professor Jamie A Davies

  9. The Concise Guide to PHARMACOLOGY 2023/24: Transporters

    Article • British Journal of Pharmacology, October 2023, Wiley

    Professor Alistair Mathie, Professor Jamie A Davies

  10. A KCNB1 gain of function variant causes developmental delay and speech apraxia but not seizures

    Article • Frontiers in Pharmacology, December 2022, Frontiers

    Professor Alistair Mathie

  11. HIV and Schistosoma Co-Exposure Leads to Exacerbated Pulmonary Endothelial Remodeling and Dysfunction Associated with Altered Cytokine Landscape

    Article • Cells, August 2022, MDPI AG

    Professor Alistair Mathie

  12. Gain and loss of TASK3 channel function and its regulation by novel variation cause KCNK9 imprinting syndrome

    Article • Genome Medicine, June 2022, Springer Science + Business Media

    Professor Alistair Mathie

  13. Aprepitant is a novel, selective activator of the K2P channel TRAAK

    Article • Biochemical and Biophysical Research Communications, January 2022, Elsevier

    Professor Alistair Mathie

  14. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Catalytic receptors

    Article • British Journal of Pharmacology, September 2021, Wiley

    Professor Alistair Mathie, Stephen Alexander

  15. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Enzymes

    Article • British Journal of Pharmacology, September 2021, Wiley

    Professor Alistair Mathie, Stephen Alexander

  16. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors

    Article • British Journal of Pharmacology, September 2021, Wiley

    Professor Alistair Mathie, Stephen Alexander, Professor of Vascular Physiology Lucie Clapp

  17. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Introduction and Other Protein Targets

    Article • British Journal of Pharmacology, September 2021, Wiley

    Professor Alistair Mathie, Stephen Alexander

  18. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Ion channels

    Article • British Journal of Pharmacology, September 2021, Wiley

    Professor Alistair Mathie, Stephen Alexander

  19. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Nuclear hormone receptors

    Article • British Journal of Pharmacology, September 2021, Wiley

    Professor Alistair Mathie, Stephen Alexander

  20. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Transporters

    Article • British Journal of Pharmacology, September 2021, Wiley

    Professor Alistair Mathie, Stephen Alexander

  21. Block of TREK and TRESK K2P channels by lamotrigine and two derivatives sipatrigine and CEN-092

    Article • Biochemistry and Biophysics Reports, July 2021, Elsevier

    Professor Alistair Mathie

  22. The Prostacyclin Analogue, Treprostinil, Used in the Treatment of Pulmonary Arterial Hypertension, is a Potent Antagonist of TREK-1 and TREK-2 Potassium Channels

    Article • Frontiers in Pharmacology, June 2021, Frontiers

    Professor Alistair Mathie, Professor of Vascular Physiology Lucie Clapp

  23. Pharmacological Approaches to Studying Potassium Channels

    Article • January 2021, Springer Science + Business Media

    Professor Alistair Mathie

  24. A “Target Class” Screen to Identify Activators of Two-Pore Domain Potassium (K2P) Channels

    Article • SLAS DISCOVERY, December 2020, SAGE Publications

    Professor Alistair Mathie

  25. Heterologous Expression of Ion Channels in Mammalian Cell Lines

    Article • October 2020, Springer Science + Business Media

    Professor Alistair Mathie

  26. TRESK is a key regulator of nocturnal suprachiasmatic nucleus dynamics and light adaptive responses

    Article • Nature Communications, September 2020, Springer Science + Business Media

    Professor Alistair Mathie

  27. TASK-3 Two-Pore Potassium Channels drive neuronal excitability of the circadian clock and entrainment to challenging light environments

    Article • July 2020, Cold Spring Harbor Laboratory Press

    Professor Alistair Mathie

  28. Opportunistic screening for atrial fibrillation by clinical pharmacists in UK general practice during the influenza vaccination season: A cross-sectional feasibility study

    Article • PLoS Medicine, July 2020, PLOS

    Professor Alistair Mathie

  29. Two-Pore Domain Potassium Channels as Drug Targets: Anesthesia and Beyond

    Article • The Annual Review of Pharmacology and Toxicology, July 2020, Annual Reviews

    Professor Alistair Mathie

  30. Pharmacists detecting atrial fibrillation in general practice: a qualitative focus group study

    Article • BJGP Open, June 2020, Royal College of General Practitioners

    Professor Alistair Mathie

  31. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Catalytic receptors

    Article • British Journal of Pharmacology, November 2019, Wiley

    Professor Alistair Mathie, Stephen Alexander

  32. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Enzymes

    Article • British Journal of Pharmacology, November 2019, Wiley

    Professor Alistair Mathie, Stephen Alexander

  33. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors

    Article • British Journal of Pharmacology, November 2019, Wiley

    Professor Alistair Mathie, Stephen Alexander, Prof daniel hoyer, Professor of Vascular Physiology Lucie Clapp

  34. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Introduction and Other Protein Targets

    Article • British Journal of Pharmacology, November 2019, Wiley

    Professor Alistair Mathie, Stephen Alexander

  35. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Ion channels

    Article • British Journal of Pharmacology, November 2019, Wiley

    Professor Alistair Mathie, Stephen Alexander, Professor Israel Hanukoglu

  36. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Nuclear hormone receptors

    Article • British Journal of Pharmacology, November 2019, Wiley

    Professor Alistair Mathie, Stephen Alexander

  37. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Transporters

    Article • British Journal of Pharmacology, November 2019, Wiley

    Professor Alistair Mathie, Stephen Alexander

  38. Pranlukast is a novel small molecule activator of the two-pore domain potassium channel TREK2

    Article • Biochemical and Biophysical Research Communications, September 2019, Elsevier

    Professor Alistair Mathie

  39. Pharmacologically reversible, loss of function mutations in the TM2 and TM4 inner pore helices of TREK-1 K2P channels

    Article • Scientific Reports, August 2019, Springer Science + Business Media

    Professor Alistair Mathie

  40. Effects of the ventilatory stimulant, doxapram on human TASK‐3 (KCNK9, K2P9.1) channels and TASK‐1 (KCNK3, K2P3.1) channels

    Article • Acta Physiologica, August 2019, Wiley

    Professor Alistair Mathie

  41. Infection in pulmonary vascular diseases: Would another consortium really be the way to go?

    Article • Global Cardiology Science and Practice, April 2019, Global Cardiology Science and Practice

    Professor Alistair Mathie

  42. Characterisation and regulation of wild type and mutant TASK-1 two pore domain potassium channels indicated in pulmonary arterial hypertension

    Article • The Journal of Physiology, October 2018, Wiley

    Professor Alistair Mathie

  43. HIV transgene expression impairs K+ channel function in the pulmonary vasculature

    Article • AJP Lung Cellular and Molecular Physiology, August 2018, American Physiological Society

    Professor Alistair Mathie

  44. Activation of TREK currents by riluzole in three subgroups of cultured mouse nodose ganglion neurons

    Article • PLoS ONE, June 2018, PLOS

    Professor Alistair Mathie

  45. Pharmacists detecting atrial fibrillation (PDAF) in primary care during the influenza vaccination season: a multisite, cross-sectional screening protocol

    Article • BMJ Open, March 2018, BMJ

    Professor Alistair Mathie

  46. GI-530159, a novel, selective, mechanosensitive two-pore-domain potassium (K2P ) channel opener, reduces rat dorsal root ganglion neuron excitability

    Article • British Journal of Pharmacology, December 2017, Wiley

    Professor Alistair Mathie

  47. TASK-1 (KCNK3) channels in the lung: from cell biology to clinical implications

    Article • European Respiratory Journal, November 2017, European Respiratory Society (ERS)

    Professor Alistair Mathie

  48. Terbinafine is a novel and selective activator of the two-pore domain potassium channel TASK3

    Article • Biochemical and Biophysical Research Communications, September 2017, Elsevier

    Professor Alistair Mathie

  49. Enhanced inflammatory cell profiles in schistosomiasis-induced pulmonary vascular remodeling

    Article • Pulmonary Circulation, January 2017, SAGE Publications

    Professor Alistair Mathie

  50. Aristolochic acid, a plant extract used in the treatment of pain and linked to Balkan endemic nephropathy, is a regulator of K2P channels

    Article • British Journal of Pharmacology, April 2016, Wiley

    Professor Alistair Mathie

  51. Two-pore domain potassium channels: potential therapeutic targets for the treatment of pain

    Article • Pflügers Archiv - European Journal of Physiology, November 2014, Springer Science + Business Media

    Professor Alistair Mathie

  52. Influence of the N Terminus on the Biophysical Properties and Pharmacology of TREK1 Potassium Channels

    Article • Molecular Pharmacology, February 2014, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Professor Alistair Mathie

  53. Enhancement of Current through Trek1 Two Pore Domain Channels by Flufenamic Acid

    Article • Biophysical Journal, January 2014, Elsevier

    Professor Alistair Mathie

  54. Recovery of Current through Mutated TASK3 Potassium Channels Underlying Birk Barel Syndrome

    Article • Molecular Pharmacology, December 2013, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Professor Alistair Mathie

  55. Enhancement of TWIK-related Acid-sensitive Potassium Channel 3 (TASK3) Two-pore Domain Potassium Channel Activity by Tumor Necrosis Factor  

    Article • Journal of Biological Chemistry, December 2013, American Society for Biochemistry & Molecular Biology (ASBMB)

    Professor Alistair Mathie

  56. GuideToPharmacology.org - an update

    Article • British Journal of Pharmacology, September 2012, Wiley

    Professor Alistair Mathie, Stephen Alexander, Dr Anthony P Davenport

  57. Guide to Receptors and Channels (GRAC), 5th edition

    Article • British Journal of Pharmacology, November 2011, Wiley

    Professor Alistair Mathie, Stephen Alexander

  58. Trafficking of Neuronal Two Pore Domain Potassium Channels

    Article • Current Neuropharmacology, September 2010, Bentham Science Publishers

    Professor Alistair Mathie

  59. SYMPOSIUM REVIEW: Gating of two pore domain potassium channels

    Article • The Journal of Physiology, August 2010, Wiley

    Professor Alistair Mathie

  60. Ion channels as novel therapeutic targets in the treatment of pain

    Article • Journal of Pharmacy and Pharmacology, August 2010, Wiley

    Professor Alistair Mathie

  61. Dominant Negative Effects of a Non-conducting TREK1 Splice Variant Expressed in Brain

    Article • Journal of Biological Chemistry, July 2010, American Society for Biochemistry & Molecular Biology (ASBMB)

    Professor Alistair Mathie

  62. Guide to Receptors and Channels (GRAC), 4th edition

    Article • British Journal of Pharmacology, November 2009, Wiley

    Professor Alistair Mathie, Stephen Alexander

  63. The M1P1 Loop of TASK3 K2P Channels Apposes the Selectivity Filter and Influences Channel Function

    Article • Journal of Biological Chemistry, April 2008, American Society for Biochemistry & Molecular Biology (ASBMB)

    Professor Alistair Mathie

  64. Guide to Receptors and Channels (GRAC), 3rd edition

    Article • British Journal of Pharmacology, March 2008, Wiley

    Professor Alistair Mathie, Stephen Alexander

  65. Identification of a region in the TASK3 two pore domain potassium channel that is critical for its blockade by methanandamide

    Article • British Journal of Pharmacology, November 2007, Wiley

    Professor Alistair Mathie

  66. TASK-3 Two-Pore Domain Potassium Channels Enable Sustained High-Frequency Firing in Cerebellar Granule Neurons

    Article • Journal of Neuroscience, August 2007, Society for Neuroscience

    Professor Alistair Mathie

  67. Gαq-Mediated Regulation of TASK3 Two-Pore Domain Potassium Channels: The Role of Protein Kinase C

    Article • Molecular Pharmacology, March 2007, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Professor Alistair Mathie

  68. Guide to Receptors and Channels, 2nd edition (2007 Revision)

    Article • British Journal of Pharmacology, February 2007, Wiley

    Professor Alistair Mathie, Stephen Alexander

  69. Neuronal two-pore-domain potassium channels and their regulation by G protein-coupled receptors

    Article • The Journal of Physiology, January 2007, Wiley

    Professor Alistair Mathie

  70. Zinc and copper: Pharmacological probes and endogenous modulators of neuronal excitability

    Article • Pharmacology & Therapeutics, September 2006, Elsevier

    Professor Alistair Mathie

  71. Guide to Receptors and Channels, 2nd edition

    Article • British Journal of Pharmacology, March 2006, Wiley

    Professor Alistair Mathie, Stephen Alexander

  72. The in Vivo Contributions of TASK-1-Containing Channels to the Actions of Inhalation Anesthetics, the α2 Adrenergic Sedative Dexmedetomidine, and Cannabinoid Agonists

    Article • Journal of Pharmacology and Experimental Therapeutics, January 2006, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Professor Alistair Mathie

  73. Modifying the Subunit Composition of TASK Channels Alters the Modulation of a Leak Conductance in Cerebellar Granule Neurons

    Article • Journal of Neuroscience, December 2005, Society for Neuroscience

    Professor Alistair Mathie

  74. Guide to Receptors and Channels, 1st Edition (2005 revision)

    Article • British Journal of Pharmacology, March 2005, Wiley

    Professor Alistair Mathie, Stephen Alexander

  75. Inhibition of the human two-pore domain potassium channel, TREK-1, by fluoxetine and its metabolite norfluoxetine

    Article • British Journal of Pharmacology, March 2005, Wiley

    Professor Alistair Mathie

  76. Selective block of the human 2-P domain potassium channel, TASK-3, and the native leak potassium current, IKSO, by zinc

    Article • The Journal of Physiology, October 2004, Wiley

    Professor Alistair Mathie

  77. Two-Pore-Domain K+ Channels Are a Novel Target for the Anesthetic Gases Xenon, Nitrous Oxide, and Cyclopropane

    Article • Molecular Pharmacology, January 2004, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Professor Alistair Mathie

  78. Neuronal ion channels and their sensitivity to extremely low frequency weak electric field effects

    Article • Radiation Protection Dosimetry, October 2003, Oxford University Press (OUP)

    Professor Alistair Mathie

  79. What are the roles of the many different types of potassium channel expressed in cerebellar granule cells?

    Article • The Cerebellum, January 2003, Springer Science + Business Media

    Professor Alistair Mathie

  80. What are the roles of the many different types of potassium channel expressed in cerebellar granule cells?

    Article • The Cerebellum, January 2003, Springer Science + Business Media

    Professor Alistair Mathie

  81. Background potassium channels move into focus

    Article • The Journal of Physiology, July 2002, Wiley

    Professor Alistair Mathie

  82. Pharmacological characterization of a non-inactivating outward current observed in mouse cerebellar Purkinje neurones

    Article • British Journal of Pharmacology, February 2002, Wiley

    Professor Alistair Mathie

  83. Inhibition of the potassium current IKSO, in cerebellar granule cells, by the inhibitors of MEK1 activation, PD 98059 and U 0126

    Article • Neuropharmacology, February 2002, Elsevier

    Professor Alistair Mathie

  84. MAMMALIAN TWO-PORE DOMAIN POTASSIUM CHANNELS

    Article • July 2001, The Physiological Society

    Professor Alistair Mathie

  85. TiPS nomenclature supplement 2001

    Article • Trends in Pharmacological Sciences, January 2001, Elsevier

    Professor Alistair Mathie

  86. The role of Ca2+stores in the muscarinic inhibition of the K+currentIK(SO)in neonatal rat cerebellar granule cells

    Article • The Journal of Physiology, December 2000, Wiley

    Professor Alistair Mathie

  87. Purinergic and muscarinic receptor activation activates a common calcium entry pathway in rat neocortical neurons and glial cells

    Article • Neuropharmacology, September 2000, Elsevier

    Professor Alistair Mathie

  88. A functional role for the two-pore domain potassium channel TASK-1 in cerebellar granule neurons

    Article • Proceedings of the National Academy of Sciences, March 2000, Proceedings of the National Academy of Sciences

    Professor Alistair Mathie

  89. A functional role for the two-pore domain potassium channel TASK-1 in cerebellar granule neurons

    Article • Proceedings of the National Academy of Sciences, March 2000, Proceedings of the National Academy of Sciences

    Professor Alistair Mathie

  90. Inhibition of delayed rectifier K+conductance in cultured rat cerebellar granule neurons by activation of calcium-permeable AMPA receptors

    Article • European Journal of Neuroscience, March 2000, Wiley

    Professor Alistair Mathie

  91. Inhibition of neuronal KV potassium currents by the antidepressant drug, fluoxetine

    Article • British Journal of Pharmacology, December 1999, Wiley

    Professor Alistair Mathie

  92. Inhibition by inorganic ions of a sustained calcium signal evoked by activation of mGlu5 receptors in rat cortical neurons and glia

    Article • British Journal of Pharmacology, December 1998, Wiley

    Professor Alistair Mathie

  93. Activation of group I metabotropic glutamate receptors elicits pH changes in cultured rat cortical glia and neurons

    Article • Neuroscience, June 1998, Elsevier

    Professor Alistair Mathie

  94. Characterization of the hyperpolarization-activated chloride current in dissociated rat sympathetic neurons

    Article • The Journal of Physiology, February 1998, Wiley

    Professor Alistair Mathie

  95. Voltage-activated potassium channels in mammalian neurons and their block by novel pharmacological agents

    Article • General Pharmacology The Vascular System, January 1998, Elsevier

    Professor Alistair Mathie

  96. Ion Channels: Molecules in Action. Edited by D. J.Aidleyand P. R.Stanfield. Pp. 340. Cambridge University Press, 1996. £17.95 paperback, ISBN 0521 49882 1. £50.00 hardback, ISBN 0 521 49531 8

    Article • Experimental Physiology, May 1997, Wiley

    Professor Alistair Mathie

  97. Is eag the answer to the M-current?

    Article • Trends in Neurosciences, January 1997, Elsevier

    Professor Alistair Mathie

  98. Effects on K+ currents in rat cerebellar granule neurones of a membrane-permeable analogue of the calcium chelator BAPTA

    Article • British Journal of Pharmacology, August 1996, Wiley

    Professor Alistair Mathie

  99. A non-inactivating K+ current sensitive to muscarinic receptor activation in rat cultured cerebellar granule neurons.

    Article • The Journal of Physiology, March 1996, Wiley

    Professor Alistair Mathie

  100. Potent block of potassium currents in rat isolated sympathetic neurones by the uncharged form of amitriptyline and related tricyclic compounds

    Article • British Journal of Pharmacology, October 1995, Wiley

    Professor Alistair Mathie

  101. Methods in neurosciences volume 19: Ion channels of excitable cells

    Article • Neuroscience, February 1995, Elsevier

    Professor Alistair Mathie

  102. Multiple G-protein-coupled pathways inhibit N-type Ca channels of neurons

    Article • Life Sciences, February 1995, Elsevier

    Professor Alistair Mathie

  103. Modulation of the gating of the transient outward potassium current of rat isolated cerebellar granule neurons by lanthanum

    Article • Pflügers Archiv - European Journal of Physiology, January 1994, Springer Science + Business Media

    Professor Alistair Mathie

  104. Block of potassium currents in rat isolated sympathetic neurones by tricyclic antidepressants and structurally related compounds

    Article • British Journal of Pharmacology, November 1993, Wiley

    Professor Alistair Mathie

  105. Characterization of muscarinic receptor subtypes inhibiting Ca2+ current and M current in rat sympathetic neurons.

    Article • Proceedings of the National Academy of Sciences, October 1992, Proceedings of the National Academy of Sciences

    Professor Alistair Mathie

  106. Inhibition of N- and L-type calcium channels by muscarinic receptor activation in rat sympathetic neurons

    Article • Neuron, May 1992, Elsevier

    Professor Alistair Mathie

  107. 5-HT3 receptor channels in dissociated rat superior cervical ganglion neurons.

    Article • The Journal of Physiology, March 1992, Wiley

    Professor Alistair Mathie

  108. Conductance and kinetic properties of single nicotinic acetylcholine receptor channels in rat sympathetic neurones.

    Article • The Journal of Physiology, July 1991, Wiley

    Professor David Colquhoun, Professor Alistair Mathie

  109. Intracellular Ca2+ buffers disrupt muscarinic suppression of Ca2+ current and M current in rat sympathetic neurons.

    Article • Proceedings of the National Academy of Sciences, January 1991, Proceedings of the National Academy of Sciences

    Professor Alistair Mathie

  110. Activation of glutamate receptors and glutamate uptake in identified macroglial cells in rat cerebellar cultures.

    Article • The Journal of Physiology, January 1991, Wiley

    Professor Alistair Mathie

  111. Rectification of currents activated by nicotinic acetylcholine receptors in rat sympathetic ganglion neurones.

    Article • The Journal of Physiology, August 1990, Wiley

    Professor David Colquhoun, Professor Alistair Mathie

  112. Chapter 5 Function of nicotinic synapses

    Article • January 1990, Elsevier

    Professor Alistair Mathie

  113. Acetylcholine receptor channels and their block by clonidine in cultured bovine chromaffin cells.

    Article • The Journal of Physiology, August 1988, Wiley

    Professor Alistair Mathie

  114. Nicotinic acetylcholine receptors of nerve and muscle: Functional aspects

    Article • Trends in Pharmacological Sciences, December 1987, Elsevier

    Professor David Colquhoun, Professor Alistair Mathie

  115. Single-Channel and Whole-Cell Currents Evoked by Acetylcholine in Dissociated Sympathetic Neurons of the Rat

    Article • Proceedings of the Royal Society B Biological Sciences, November 1987, Royal Society Publishing

    Professor David Colquhoun, Professor Alistair Mathie

  116. Interactions between the effects of yohimbine, clonidine and [Ca]o on the electrical response of the mouse vas deferens

    Article • British Journal of Pharmacology, August 1986, Wiley

    Professor Alistair Mathie

  117. Ion channels activated by acetylcholine and γ-aminobutyric acid in freshly dissociated sympathetic neurones of the rat

    Article • Neuroscience Letters, May 1986, Elsevier

    Professor Alistair Mathie

  118. Facilitation at single release sites of a sympathetic neuroeffector junction in the mouse.

    Article • The Journal of Physiology, April 1984, Wiley

    Professor Alistair Mathie

  119. α-ADRENORECEPTORS AND FACILITATION AT A SYMPATHETIC NEUROEFFECTOR JUNCTION

    Article • Journal of Autonomic Pharmacology, March 1984, Wiley

    Professor Alistair Mathie

  120. Neuronal Potassium Channels

    Article • Springer Science + Business Media

    Professor Alistair Mathie